UCB - Des Atouts

Prix De L'Action
239.00
Variation Quotidienne
-7.30 -2.96%
Mensuellement
-5.87%
Annuel
59.65%
Q2 Prévisions
233.96




Des Atouts Changement Date
Alcon AG USD 31.56B 31M 2025-12
Almirall EUR 2.34B 29.21M 2025-12
Amarin USD 670.78M 10.96M 2025-12
argenx SE USD 7.18B 973.07M 2025-06
AstraZeneca USD 114.07B 382M 2025-12
Bayer EUR 104.54B 331M 2025-12
Galapagos EUR 3.41B 105.39M 2025-12
Genmab DKK 12.87B 5.85B 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Merck EUR 51.53B 600M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Orion EUR 2.08B 69.2M 2026-03
Recordati EUR 5.3B 122.58M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
UCB EUR 18.16B 971M 2025-12
Unibail Rodamco EUR 49.68B 1.23B 2025-12